Company Information

CIN
Status
Date of Incorporation
11 July 2001
Listing Status
Unlisted
State
Delhi
ROC
ROC Delhi
Industry
Allopathic Pharmaceutical
Sub Category
Non-govt company
Last Balance Sheet
31 March 2023
Last Annual Meeting
28 September 2023
Paid Up Capital
406,795,000
Authorised Capital
510,000,000
Financials All Documents available from MCA @Rs 799/-

Directors

Ajay Kumar Sharma
Ajay Kumar Sharma
Director/Designated Partner
almost 2 years ago
Varun Suri
Varun Suri
Director/Designated Partner
almost 2 years ago
Bhupender Raj Wadhwa
Bhupender Raj Wadhwa
Director/Designated Partner
over 10 years ago
Sukhcharan Singh
Sukhcharan Singh
Director/Designated Partner
almost 19 years ago
Sanjay Suri
Sanjay Suri
Managing Director
almost 22 years ago

Past Directors

Alok Kumar Srivastava
Alok Kumar Srivastava
Company Secretary
over 13 years ago
Nakka Krishnamurthy Chandrasekhar
Nakka Krishnamurthy Chandrasekhar
Director
over 20 years ago

Registered Trademarks

Dr. Morepen Paincoxia Dr. Morepen

[Class : 5] Medicinal And Pharmaceutical Preparations

Napaspeed Dr. Morepen

[Class : 5] Medicinal & Pharmaceutical Preparations.

Heartme Dr. Morepen

[Class : 5] Medicinal And Pharmaceutical Preparations.
View +423 more Brands for Dr. Morepen Limited.

Charges

88 Lak
18 May 2015
Bmw India Financial Services Private Limited
44 Lak
18 May 2015
Bmw India Financial Services Private Limited
44 Lak
09 August 2006
Lakshmi Vilas Bank Limited
10 Crore
09 August 2006
Lakshmi Vilas Bank Limited
0
18 May 2015
Bmw India Financial Services Private Limited
0
18 May 2015
Bmw India Financial Services Private Limited
0
09 August 2006
Lakshmi Vilas Bank Limited
0
18 May 2015
Bmw India Financial Services Private Limited
0
18 May 2015
Bmw India Financial Services Private Limited
0
09 August 2006
Lakshmi Vilas Bank Limited
0
18 May 2015
Bmw India Financial Services Private Limited
0
18 May 2015
Bmw India Financial Services Private Limited
0

Documents

Form AOC-4(XBRL)-03042021_signed
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-29122020
XBRL document in respect Consolidated financial statement-29122020
Form DPT-3-18122020-signed
List of share holders, debenture holders;-26102020
Copy of MGT-8-26102020
Form MGT-7-26102020_signed
Form MGT-14-26092020_signed
Form DPT-3-07092020-signed
Form MGT-14-06032020_signed
Copy(s) of resolution(s) along with copy of explanatory statement under section 173-06032020
Optional Attachment-(1)-06032020
Form MGT-7-16122019_signed
List of share holders, debenture holders;-13122019
Copy of MGT-8-13122019
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-06112019
XBRL document in respect Consolidated financial statement-06112019
Form AOC-4(XBRL)-06112019_signed
Form DPT-3-28062019
List of share holders, debenture holders;-29122018
Copy of MGT-8-29122018
Form MGT-7-29122018_signed
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-30102018
XBRL document in respect Consolidated financial statement-30102018
Form AOC-4(XBRL)-30102018_signed
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-07062018
Form DIR-12-26022018_signed
Optional Attachment-(1)-23022018
List of share holders, debenture holders;-11122017
Form MGT-7-11122017_signed